Jane Wasman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane Wasman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Wasman. Jane Wasman is Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Ex VP , General Counsel & Sec in ACORDA THERAPEUTICS INC ($ACOR) and President, Intl and GC in ACORDA THERAPEUTICS INC ($ACOR) and Director in ATHERSYS, INC / NEW ($ATHX) and Director in SELLAS Life Sciences Group, Inc. ($GALE).
Latest Insider Trading Transactions of Jane Wasman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ATHX, RIGL, SLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 8.00 | 7,500 | 60,000 | 7,500 | |
| Nov 16 2020 | ATHX | ATHERSYS, INC / NE ... | Wasman Jane | Director | Option Exercise | A | 1.88 | 100,000 | 188,000 | 100,000 | |
| Nov 16 2020 | ATHX | ATHERSYS, INC / NE ... | Wasman Jane | Director | Option Exercise | A | 1.88 | 100,000 | 188,000 | 100,000 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Wasman Jane | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Wasman Jane | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| Mar 16 2020 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
| Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 1.60 | 2,227 | 3,553 | 117,420 | 119.6 K to 117.4 K (-1.86 %) |
| Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 1.60 | 2,227 | 3,553 | 117,420 | 119.6 K to 117.4 K (-1.86 %) |
| Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 2.41 | 80,000 | 192,800 | 80,000 | |
| May 24 2019 | RIGL | RIGEL PHARMACEUTIC ... | Wasman Jane | Director | Option Exercise | A | 2.02 | 13,750 | 27,775 | 13,750 | |
| Apr 03 2019 | RIGL | RIGEL PHARMACEUTIC ... | Wasman Jane | Director | Option Exercise | A | 2.42 | 80,000 | 193,600 | 80,000 | |
| Mar 18 2019 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
| Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 13.51 | 21,355 | 288,506 | 21,355 | |
| Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 12,813 | 0 | 119,647 | 106.8 K to 119.6 K (+11.99 %) |
| Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 13.38 | 953 | 12,751 | 106,834 | 107.8 K to 106.8 K (-0.88 %) |
| Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 2,500 | 0 | 107,787 | 105.3 K to 107.8 K (+2.37 %) |
| Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.52 | 3,067 | 62,947 | 105,287 | 108.4 K to 105.3 K (-2.83 %) |
| Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 20.28 | 955 | 19,367 | 108,354 | 109.3 K to 108.4 K (-0.87 %) |
| Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 2,500 | 0 | 109,309 | 106.8 K to 109.3 K (+2.34 %) |
| Jun 13 2018 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
| Mar 15 2018 | GALE | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
| Mar 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 25.65 | 2,470 | 63,356 | 106,809 | 109.3 K to 106.8 K (-2.26 %) |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 19.81 | 2,980 | 59,034 | 0 | |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 25.95 | 2,274 | 59,010 | 109,279 | 111.6 K to 109.3 K (-2.04 %) |
| Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 19.81 | 2,980 | 59,034 | 111,553 | 108.6 K to 111.6 K (+2.74 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 6,463 | 0 | 108,573 | 102.1 K to 108.6 K (+6.33 %) |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 19.81 | 34,520 | 683,841 | 2,980 | |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 28.63 | 350 | 10,020 | 102,110 | 102.5 K to 102.1 K (-0.34 %) |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 27.58 | 34,170 | 942,299 | 102,460 | 136.6 K to 102.5 K (-25.01 %) |
| Jan 23 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 19.81 | 34,520 | 683,841 | 136,630 | 102.1 K to 136.6 K (+33.81 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.52 | 4,564 | 93,662 | 102,110 | 106.7 K to 102.1 K (-4.28 %) |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 27.48 | 12,500 | 343,438 | 12,500 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 5,000 | 0 | 106,674 | 101.7 K to 106.7 K (+4.92 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 21.30 | 100 | 2,130 | 101,674 | 101.8 K to 101.7 K (-0.10 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.72 | 3,247 | 67,270 | 101,774 | 105 K to 101.8 K (-3.09 %) |
| Oct 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.78 | 3,750 | 77,927 | 105,021 | 108.8 K to 105 K (-3.45 %) |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 27.32 | 500 | 13,660 | 108,771 | 109.3 K to 108.8 K (-0.46 %) |
| Sep 27 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 8.50 | 500 | 4,250 | 109,271 | 108.8 K to 109.3 K (+0.46 %) |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 22.13 | 8,647 | 191,358 | 54,536 | |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 22.13 | 8,647 | 191,358 | 108,771 | 100.1 K to 108.8 K (+8.64 %) |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 22.13 | 8,647 | 191,358 | 54,536 | |
| Jun 14 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 22.13 | 8,647 | 191,358 | 108,771 | 100.1 K to 108.8 K (+8.64 %) |
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 26.40 | 15,000 | 396,000 | 15,000 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 35.53 | 30,163 | 1,071,691 | 30,163 | |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 10,751 | 62,893 | 0 | |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 43.10 | 10,751 | 463,395 | 100,124 | 110.9 K to 100.1 K (-9.70 %) |
| Dec 28 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 10,751 | 62,893 | 110,875 | 100.1 K to 110.9 K (+10.74 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 5,342 | 31,251 | 10,751 | |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 42.07 | 8,455 | 355,726 | 100,124 | 108.6 K to 100.1 K (-7.79 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 43.00 | 5,342 | 229,706 | 108,579 | 113.9 K to 108.6 K (-4.69 %) |
| Dec 24 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 5,342 | 31,251 | 113,921 | 108.6 K to 113.9 K (+4.92 %) |
| Dec 22 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 42.00 | 817 | 34,314 | 108,579 | 109.4 K to 108.6 K (-0.75 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 6.00 | 3,277 | 19,662 | 0 | |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 40.00 | 3,277 | 131,080 | 109,396 | 112.7 K to 109.4 K (-2.91 %) |
| Dec 21 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 6.00 | 3,277 | 19,662 | 112,673 | 109.4 K to 112.7 K (+3.00 %) |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 38.08 | 5,523 | 210,294 | 109,396 | 114.9 K to 109.4 K (-4.81 %) |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 6.00 | 7,915 | 47,490 | 3,277 | |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 5.85 | 8,907 | 52,106 | 16,093 | |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 6.00 | 7,915 | 47,490 | 114,919 | 107 K to 114.9 K (+7.40 %) |
| Nov 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 5.85 | 8,907 | 52,106 | 107,004 | 98.1 K to 107 K (+9.08 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 31.89 | 3,219 | 102,658 | 98,097 | 101.3 K to 98.1 K (-3.18 %) |
| Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 30.91 | 531 | 16,413 | 101,316 | 101.8 K to 101.3 K (-0.52 %) |
| Aug 27 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 31.37 | 10,000 | 313,700 | 10,000 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 35.74 | 41,191 | 1,472,166 | 41,191 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 7,269 | 0 | 101,847 | 94.6 K to 101.8 K (+7.69 %) |
| Sep 27 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Ex VP , General Cou ... | Option Exercise | A | 8.50 | 500 | 4,250 | 84,961 |
Page: 1